C. Boz Et Al. , "Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , vol.23, Paris, France, pp.327-328, 2017
Boz, C. Et Al. 2017. Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , (Paris, France), 327-328.
Boz, C., Ozakbas, S., Terzi, M., Turkoglu, R., Akman, G., Efendi, H., ... Akcali, A.(2017). Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) (pp.327-328). Paris, France
Boz, CAVİT Et Al. "Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 2017
Boz, CAVİT Et Al. "Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.327-328, 2017
Boz, C. Et Al. (2017) . "Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.327-328.
@conferencepaper{conferencepaper, author={CAVİT BOZ Et Al. }, title={Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis}, congress name={7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)}, city={Paris}, country={France}, year={2017}, pages={327-328} }